ES2283012T3
(es)
|
1996-01-04 |
2007-10-16 |
Novartis Vaccines And Diagnostics, Inc. |
Bacterioferritina de helicobacter pylori.
|
US6001602A
(en)
|
1997-07-23 |
1999-12-14 |
Smithkline Beecham Corporation |
DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
|
US5882892A
(en)
|
1997-07-23 |
1999-03-16 |
Smithkline Beecham Corporation |
Asps
|
EP2218731A1
(fr)
*
|
1997-11-28 |
2010-08-18 |
Merck Serono Biodevelopment |
Séquence génomique de Chlamydia pneumoniae, polypeptides, fragments et leurs utilisations, en particulier pour le diagnostic, la prévention et le traitement de l'infection
|
US20030147924A1
(en)
*
|
1998-07-27 |
2003-08-07 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
JP2002525027A
(ja)
*
|
1998-07-27 |
2002-08-13 |
コナート ラボラトリーズ リミテッド |
Chlamydia抗原および対応するDNAフラグメントならびにそれらの使用
|
WO2000006739A2
(fr)
*
|
1998-07-27 |
2000-02-10 |
Connaught Laboratories Limited |
Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
|
US6660275B2
(en)
|
1998-07-27 |
2003-12-09 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
EP1108033A2
(fr)
*
|
1998-07-27 |
2001-06-20 |
Aventis Pasteur Limited |
ANTIGENES DE $i(CHLAMYDIA) ET FRAGMENTS D'ADN CORRESPONDANTS, ET UTILISATIONS DE CEUX-CI
|
US6693087B1
(en)
|
1998-08-20 |
2004-02-17 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding POMP91A protein of Chlamydia
|
US6686339B1
(en)
|
1998-08-20 |
2004-02-03 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
|
MXPA01001639A
(es)
*
|
1998-08-20 |
2004-09-06 |
Connaught Lab |
Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
|
WO2000011180A1
(fr)
*
|
1998-08-20 |
2000-03-02 |
Connaught Laboratories Limited |
MOLECULES D'ACIDE NUCLEIQUE CODANT LA PROTEINE POMP91A DE $i(CHLAMYDIA)
|
CA2340330A1
(fr)
*
|
1998-08-20 |
2000-03-02 |
Aventis Pasteur Limited |
Molecules d'acide nucleique codant la proteine membrane d'inclusion c de chlamydia
|
US6403101B1
(en)
*
|
1998-10-28 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6649370B1
(en)
*
|
1998-10-28 |
2003-11-18 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
MXPA01004291A
(es)
*
|
1998-10-28 |
2003-06-09 |
Aventis Pasteur |
Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
|
US6872814B2
(en)
|
1998-10-29 |
2005-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6403102B1
(en)
|
1998-10-29 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6607730B1
(en)
|
1998-11-02 |
2003-08-19 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6822071B1
(en)
*
|
1998-11-12 |
2004-11-23 |
The Regents Of The University Of California |
Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
|
WO2000032794A2
(fr)
*
|
1998-12-01 |
2000-06-08 |
Aventis Pasteur Limited |
Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation
|
JP2002531093A
(ja)
|
1998-12-01 |
2002-09-24 |
アベンティス、パストゥール、リミテッド |
クラミジア抗原および対応するdna断片ならびにその使用
|
US6447779B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds for the diagnosis of Chlamydial infection
|
US20020061848A1
(en)
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6555115B1
(en)
|
1998-12-08 |
2003-04-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6432916B1
(en)
|
1998-12-08 |
2002-08-13 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6448234B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6565856B1
(en)
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP1144642B1
(fr)
|
1998-12-08 |
2010-05-26 |
Corixa Corporation |
Composes et procedes pour le traitement et le diagnostic d'infections par le chlamydia
|
EP1140999A1
(fr)
|
1998-12-23 |
2001-10-10 |
Aventis Pasteur Limited |
ANTIGENES DE $i(CHLAMYDIA) ET FRAGMENTS D'ADN CORRESPONDANTS UTILISATIONS DE CEUX-CI
|
US7297341B1
(en)
|
1998-12-23 |
2007-11-20 |
Sanofi Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6808713B1
(en)
|
1998-12-28 |
2004-10-26 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
DE69938059T2
(de)
*
|
1998-12-28 |
2009-01-08 |
Sanofi Pasteur Ltd., Toronto |
Chlamydia antigene, entsprechende dna-fragmente und ihre verwendungen
|
GB9902555D0
(en)
*
|
1999-02-05 |
1999-03-24 |
Neutec Pharma Plc |
Medicament
|
EP1163342B1
(fr)
|
1999-03-12 |
2008-12-10 |
Aventis Pasteur Limited |
Antigenes chlamydia, fragments d'adn correspondants, et leurs utilisations
|
WO2000066739A2
(fr)
*
|
1999-05-03 |
2000-11-09 |
Aventis Pasteur Limited |
Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
|
WO2001002575A1
(fr)
*
|
1999-06-30 |
2001-01-11 |
Aventis Pasteur Limited |
Antigenes anti-chlamydia, leurs fragments d'adn correspondants et leurs utilisations
|
AU7398300A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU7398600A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001021810A1
(fr)
*
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Antigenes de chlamydia, fragments d'adn correspondants et leurs utilisations
|
WO2001021806A1
(fr)
*
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
|
EP1220924A1
(fr)
*
|
1999-09-17 |
2002-07-10 |
Aventis Pasteur Limited |
Antigenes de chlamydia et fragments d'adn correspondants et utilisations de ces derniers
|
NZ517952A
(en)
*
|
1999-09-20 |
2004-01-30 |
Aventis Pasteur |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6632663B1
(en)
|
1999-09-22 |
2003-10-14 |
Aventis Pasteur Limited |
DNA immunization against chlamydia infection
|
AU7732000A
(en)
*
|
1999-09-29 |
2001-04-30 |
Mara Diaz |
Method of identifying pathogenic cryptococci
|
EP1094069B2
(fr)
*
|
1999-10-18 |
2008-04-23 |
Intervet International BV |
ADN codant pour la protéine structurelle-1 du virus de l'anémie infectieuse du saumon et ses utilisations
|
AU1375501A
(en)
*
|
1999-11-12 |
2001-05-30 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
WO2001036456A2
(fr)
*
|
1999-11-15 |
2001-05-25 |
Aventis Pasteur Limited |
Antigenes de chlamydia, fragments d'adn correspondants et leurs utilisations
|
AU1375701A
(en)
*
|
1999-11-15 |
2001-05-30 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
DE19959650A1
(de)
*
|
1999-12-10 |
2001-06-13 |
Degussa |
Neue für die Gene sdhA, sdhB und sdhC codierende Nukleotidsequenzen
|
AU2138501A
(en)
*
|
1999-12-22 |
2001-07-03 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
AU2138601A
(en)
*
|
1999-12-22 |
2001-07-03 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
NZ520200A
(en)
*
|
1999-12-22 |
2004-04-30 |
Aventis Pasteur |
Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product
|
CA2398467C
(fr)
*
|
2000-01-31 |
2010-06-29 |
Asahi Kasei Kabushiki Kaisha |
Anticorps de detection de chlamydia pneumoniae
|
US20030100706A1
(en)
*
|
2000-04-04 |
2003-05-29 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020082402A1
(en)
*
|
2000-04-04 |
2002-06-27 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020071831A1
(en)
*
|
2000-04-04 |
2002-06-13 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020132994A1
(en)
*
|
2000-04-04 |
2002-09-19 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020094965A1
(en)
*
|
2000-04-04 |
2002-07-18 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP1278855B1
(fr)
|
2000-04-21 |
2008-03-12 |
Corixa Corporation |
Composes et procedes pour le traitement et le diagnostic d'une infection de chlamydia
|
EP1792995A3
(fr)
|
2000-05-08 |
2007-06-13 |
Sanofi Pasteur Limited |
Antigènes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
|
EP1282718B1
(fr)
*
|
2000-05-08 |
2006-12-20 |
Sanofi Pasteur Limited |
Antigenes de chlamydia, fragments d'adn correspondants et utilisations de tels antigenes
|
ATE440861T1
(de)
*
|
2000-07-03 |
2009-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
AUPQ954000A0
(en)
*
|
2000-08-18 |
2000-09-14 |
Queensland University Of Technology |
Novel diagnostic agents and uses therefor
|
US6539102B1
(en)
|
2000-09-01 |
2003-03-25 |
Large Scale Proteomics |
Reference database
|
US6980674B2
(en)
|
2000-09-01 |
2005-12-27 |
Large Scale Proteomics Corp. |
Reference database
|
US7537772B1
(en)
*
|
2000-10-02 |
2009-05-26 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia protein, gene sequence and the uses thereof
|
US7731980B2
(en)
|
2000-10-02 |
2010-06-08 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia PMP proteins, gene sequences and uses thereof
|
MXPA03003690A
(es)
|
2000-10-27 |
2004-05-05 |
Chiron Spa |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
US6682889B1
(en)
|
2000-11-08 |
2004-01-27 |
Becton, Dickinson And Company |
Amplification and detection of organisms of the Chlamydiaceae family
|
US20070149474A1
(en)
*
|
2000-12-15 |
2007-06-28 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
|
US20030059896A1
(en)
*
|
2000-12-21 |
2003-03-27 |
Shire Biochem Inc. |
Novel chlamydia antigens and corresponding DNA fragments
|
GB0102929D0
(en)
*
|
2001-02-06 |
2001-03-21 |
Inpharmatica Ltd |
Novel proteins
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
BR0208786A
(pt)
*
|
2001-04-09 |
2004-03-09 |
Allan Christian Shaw |
Métodod para identificação de proteìnas de bactérias intracelulares
|
US6891085B2
(en)
*
|
2001-04-20 |
2005-05-10 |
Pioneer Hi-Bred International, Inc. |
Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
NZ562929A
(en)
|
2001-12-12 |
2009-07-31 |
Novartis Vaccines & Diagnostic |
Immunisation against chlamydia trachomatis
|
GB0203403D0
(en)
|
2002-02-13 |
2002-04-03 |
Chiron Spa |
Chlamydia cytotoxic-T cell epitopes
|
EP2572707A3
(fr)
|
2002-02-20 |
2013-11-06 |
Novartis Vaccines and Diagnostics, Inc. |
Microparticules avec des molécules contenant un polypeptide adsorbé
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
DK2395073T3
(en)
|
2002-11-01 |
2017-10-23 |
Glaxosmithkline Biologicals Sa |
Process for drying.
|
US20070059329A1
(en)
|
2002-11-15 |
2007-03-15 |
Nathalie Norais |
Unexpected surface proteins in meningococcus
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
KR100532665B1
(ko)
*
|
2002-11-28 |
2005-12-02 |
주식회사 바이오메드랩 |
나이세리아속 균 탐지용 프로브, 이를 이용한나이세리아속 균의 유전형 분석키트 및 유전형 분석방법
|
WO2004060396A2
(fr)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Immunogenes contenant des compositions de phospholipide
|
US20070003568A1
(en)
*
|
2003-02-24 |
2007-01-04 |
Alice Dautry-Varsat |
Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
|
EP2258365B1
(fr)
|
2003-03-28 |
2013-05-29 |
Novartis Vaccines and Diagnostics, Inc. |
Utilisation de composés organiques pour potentialiser l'immunité
|
WO2004087924A2
(fr)
*
|
2003-03-31 |
2004-10-14 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Procede d'apport de substances a des micro-organismes intracellulaires
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
WO2005020964A1
(fr)
|
2003-06-02 |
2005-03-10 |
Chiron Corporation |
Compositions immunogenes basees sur des microparticules comprenant des antigenes contenant de l'anatoxine adsorbee et des polysaccharides
|
EP1768662A2
(fr)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
免疫増強用の化合物
|
EP1784211A4
(fr)
|
2004-07-29 |
2010-06-30 |
Novartis Vaccines & Diagnostic |
Compositions immunogenes pour bacteries a gram positif telles que streptococcus agalactiae
|
ES2389562T3
(es)
|
2004-10-25 |
2012-10-29 |
Statens Seruminstitut |
Antígenos de Chlamydia trachomatis para uso en vacuna y diagnóstico
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
CN101203529A
(zh)
|
2005-02-18 |
2008-06-18 |
诺华疫苗和诊断公司 |
来自脑膜炎/脓毒症相关性大肠杆菌的蛋白质和核酸
|
SG160329A1
(en)
|
2005-02-18 |
2010-04-29 |
Novartis Vaccines & Diagnostic |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
JP2006273805A
(ja)
*
|
2005-03-30 |
2006-10-12 |
Yamaguchi Univ |
肺炎クラミジアのIncA2蛋白質、クラミジアのInc蛋白質群およびその利用方法
|
US8541007B2
(en)
|
2005-03-31 |
2013-09-24 |
Glaxosmithkline Biologicals S.A. |
Vaccines against chlamydial infection
|
AU2006254891B2
(en)
|
2005-06-06 |
2011-04-14 |
Gen-Probe Incorporated |
Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample
|
JP2009511636A
(ja)
|
2005-10-18 |
2009-03-19 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
アルファウイルスレプリコン粒子による粘膜免疫および全身免疫
|
JP5215865B2
(ja)
|
2005-11-22 |
2013-06-19 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
ノロウイルス抗原およびサポウイルス抗原
|
DE102006003814A1
(de)
*
|
2006-01-26 |
2007-08-02 |
Sirs-Lab Gmbh |
Verfahren zur in-vitro-Diagnose von Chlamydophila pneumoniae Infektionen
|
CA2646539A1
(fr)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Composes d'imidazoquinoxaline utilises en tant qu'immunomodulateurs
|
EP2064230A2
(fr)
|
2006-08-16 |
2009-06-03 |
Novartis AG |
Immunogènes pour escherichia coli uropathogène
|
WO2008136867A2
(fr)
*
|
2006-12-04 |
2008-11-13 |
Auburn University |
Vaccin contre chlamydia pneumoniae et procédés pour l'administration de ce vaccin
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
EP2511291A3
(fr)
*
|
2007-06-18 |
2012-11-07 |
Intercell AG |
Antigènes de Chlamydia
|
RU2471497C2
(ru)
|
2007-09-12 |
2013-01-10 |
Новартис Аг |
Мутантные антигены gas57 и антитела против gas57
|
EP2227250A4
(fr)
|
2007-12-03 |
2011-07-06 |
Harvard College |
Antigènes de chlamydia
|
WO2009081274A2
(fr)
|
2007-12-21 |
2009-07-02 |
Novartis Ag |
Formes mutantes de la streptolysine o
|
US8846003B2
(en)
|
2008-03-27 |
2014-09-30 |
Symic Biomedical, Inc. |
Collagen-binding synthetic peptidoglycans, preparation, and methods of use
|
DK2349520T3
(en)
|
2008-10-27 |
2016-08-15 |
Glaxosmithkline Biologicals Sa |
Purification Procedure for Group A Streptococcus Carbohydrate
|
BRPI1005670A8
(pt)
|
2009-01-05 |
2017-12-26 |
Epitogenesis Inc |
composições adjuvantes e processos de uso.
|
CA2749367A1
(fr)
|
2009-01-12 |
2010-07-15 |
Novartis Ag |
Antigenes a domaines cna_b dans des vaccins contre des bacteries a gram positif
|
US8568732B2
(en)
|
2009-03-06 |
2013-10-29 |
Novartis Ag |
Chlamydia antigens
|
AU2010352695B2
(en)
|
2009-09-30 |
2014-08-21 |
Glaxosmithkline Biologicals S.A. |
Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
EP3199177A1
(fr)
|
2009-10-30 |
2017-08-02 |
GlaxoSmithKline Biologicals S.A. |
Purification de saccharides capsulaires de staphylococcus aureus de type 5 et de type 8
|
AU2011243039B2
(en)
*
|
2010-04-16 |
2015-01-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Real time PCR assay for detection of bacterial respiratory pathogens
|
CN102933267B
(zh)
|
2010-05-28 |
2015-05-27 |
泰特里斯在线公司 |
交互式混合异步计算机游戏基础结构
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
EP2655389A2
(fr)
|
2010-12-24 |
2013-10-30 |
Novartis AG |
Composés
|
ES2708076T3
(es)
|
2011-05-24 |
2019-04-08 |
Symic Ip Llc |
Peptidoglicanos sintéticos que se unen al ácido hialurónico, preparación y métodos de uso
|
CN103717235A
(zh)
|
2011-06-24 |
2014-04-09 |
埃皮托吉尼西斯有限公司 |
作为抗原特异性免疫调节剂的包含选择的载体、维生素、单宁和类黄酮的组合的药物组合物
|
CN103917245B
(zh)
|
2011-09-14 |
2017-06-06 |
葛兰素史密丝克莱恩生物有限公司 |
用于制备糖‑蛋白质糖缀合物的方法
|
CA2854934A1
(fr)
|
2011-11-07 |
2013-05-16 |
Novartis Ag |
Molecule porteuse comprenant un antigene spr0096 et un antigene spr2021
|
MX2014014067A
(es)
|
2012-05-22 |
2015-02-04 |
Novartis Ag |
Conjugado de serogrupo x de meningococo.
|
KR20150130419A
(ko)
|
2013-03-15 |
2015-11-23 |
시믹 바이오메디칼, 인크. |
세포외 기질 결합성 합성 펩티도글리칸
|
WO2015106345A1
(fr)
*
|
2014-01-16 |
2015-07-23 |
Mcmaster University |
Protéines injectisomes à sécrétion de type iii pour le traitement et la prévention d'infections chlamydiennes
|
US10772931B2
(en)
|
2014-04-25 |
2020-09-15 |
Purdue Research Foundation |
Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
|
BE1024634B1
(fr)
|
2016-04-05 |
2018-05-14 |
Gsk Vaccines S.R.L. |
Compositions immunogenes
|
CN110809478A
(zh)
|
2017-07-07 |
2020-02-18 |
斯米克Ip有限公司 |
合成的生物缀合物
|
CN108875000B
(zh)
*
|
2018-06-14 |
2021-12-28 |
广东工业大学 |
一种融合多句法结构的语义关系分类方法
|
CN109180822B
(zh)
*
|
2018-11-14 |
2021-08-10 |
上海交通大学 |
一种猪链球菌b细胞优势表位串联疫苗及其制备方法
|
KR102422293B1
(ko)
*
|
2020-08-24 |
2022-07-18 |
수원대학교산학협력단 |
Erm 단백질과 상호작용하는 Helix 73 유래 RNA 분자 및 이의 이용 방법
|
CN112119907A
(zh)
*
|
2020-09-21 |
2020-12-25 |
连云港市农业科学院 |
一种洋葱全不育制种方法
|
CN114137209B
(zh)
*
|
2021-02-01 |
2024-03-01 |
中国水产科学研究院黄海水产研究所 |
一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用
|